Compile Data Set for Download or QSAR
maximum 50k data
Report error Found 9 of ic50 for monomerid = 50400815
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
Csir-National Chemical Laboratory

Curated by ChEMBL
LigandPNGBDBM50400815((S)-VENLAFAXINE | VENLAFAXINE)
Affinity DataIC50:  6nMAssay Description:Inhibition of human SERT expressed in HEK293 cells assessed as decrease in [3H]-serotonin reuptake after 10 mins by scintillation counting methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
Csir-National Chemical Laboratory

Curated by ChEMBL
LigandPNGBDBM50400815((S)-VENLAFAXINE | VENLAFAXINE)
Affinity DataIC50:  7nMAssay Description:Inhibition of SERTMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
Csir-National Chemical Laboratory

Curated by ChEMBL
LigandPNGBDBM50400815((S)-VENLAFAXINE | VENLAFAXINE)
Affinity DataIC50:  20nMAssay Description:Inhibition of SERT (unknown origin) assessed as serotonin reuptakeMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
University of California Davis

Curated by ChEMBL
LigandPNGBDBM50400815((S)-VENLAFAXINE | VENLAFAXINE)
Affinity DataIC50:  149nMAssay Description:Inhibition of NET (unknown origin) assessed as noradrenaline reuptakeMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
University of California Davis

Curated by ChEMBL
LigandPNGBDBM50400815((S)-VENLAFAXINE | VENLAFAXINE)
Affinity DataIC50:  754nMAssay Description:Inhibition of NETMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
University of California Davis

Curated by ChEMBL
LigandPNGBDBM50400815((S)-VENLAFAXINE | VENLAFAXINE)
Affinity DataIC50:  754nMAssay Description:Inhibition of human NET expressed in MDCK cells assessed as decrease in [3H]-noradrenaline reuptake after 10 mins by scintillation counting methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
University of California Davis

Curated by ChEMBL
LigandPNGBDBM50400815((S)-VENLAFAXINE | VENLAFAXINE)
Affinity DataIC50:  4.43E+3nMAssay Description:Inhibition of DAT (unknown origin) assessed as dopamine reuptakeMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
University of California Davis

Curated by ChEMBL
LigandPNGBDBM50400815((S)-VENLAFAXINE | VENLAFAXINE)
Affinity DataIC50:  6.67E+3nMAssay Description:Inhibition of DATMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
University of California Davis

Curated by ChEMBL
LigandPNGBDBM50400815((S)-VENLAFAXINE | VENLAFAXINE)
Affinity DataIC50:  6.67E+3nMAssay Description:Inhibition of human DAT expressed in CHOK1 cells assessed as decrease in [3H]-dopamine reuptake after 10 mins by scintillation counting methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed